0001477932-21-003495.txt : 20210524 0001477932-21-003495.hdr.sgml : 20210524 20210524084823 ACCESSION NUMBER: 0001477932-21-003495 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210521 FILED AS OF DATE: 20210524 DATE AS OF CHANGE: 20210524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Robert Steven CENTRAL INDEX KEY: 0001412747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55908 FILM NUMBER: 21951362 MAIL ADDRESS: STREET 1: 7633 E. 63RD PLACE, #220 CITY: TULSA STATE: OK ZIP: 74133 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371765151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805-824-0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 4 1 form4.xml FORM 4 X0306 4 2021-05-21-05:00 false 0001643301 Cure Pharmaceutical Holding Corp. CURR 0001412747 Davidson Robert Steven 1620 BEACON PLACE OXNARD CA 93022 true true false false Chief Executive Officer Common Stock 2021-05-21-05:00 4 P false 7400 0.709 A 549756 D This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $0.70000 to $0.71950. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 3 decimal points. /s/ Robert Davidson 2021-05-24-05:00